AstraZeneca(AZN) - 2024 Q1 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Conference Call April 25, 2024 6:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director and Chief Executive Officer Aradhana Sarin - Executive Director and Chief Financial Officer David Fredrickson - Executive Vice President of Oncology Susan Galbraith - Executive Vice President of Oncology R&D Ruud Dobber - Executive Vice President of BioPharmaceuticals Business Unit Sharon Barr - Executive Vice President of B ...